NGM Annual Current Assets
$156.44 M
-$132.41 M-45.84%
31 December 2023
Summary:
As of February 3, 2025, NGM annual total current assets is $156.44 million, with the most recent change of -$132.41 million (-45.84%) on December 31, 2023. During the last 3 years, it has fallen by -$151.98 million (-49.28%).NGM Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NGM Quarterly Current Assets
$156.44 M
-$20.59 M-11.63%
31 December 2023
Summary:
As of February 3, 2025, NGM quarterly total current assets is $156.44 million, with the most recent change of -$20.59 million (-11.63%) on December 31, 2023. Over the past year, it has dropped by -$86.08 million (-35.49%).NGM Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NGM Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -45.8% | -35.5% |
| 3 y3 years | -49.3% | -49.3% |
| 5 y5 years | -27.1% | -27.1% |
NGM Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -58.8% | -63.3% |
NGM Biopharmaceuticals Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $12.42 M(-33.0%) | $156.44 M(-11.6%) |
| Sept 2023 | - | $177.04 M(-13.4%) |
| June 2023 | - | $204.40 M(-15.7%) |
| Mar 2023 | - | $242.53 M(-16.0%) |
| Dec 2022 | $18.54 M(-19.8%) | $288.86 M(-8.5%) |
| Sept 2022 | - | $315.70 M(-1.0%) |
| June 2022 | - | $318.84 M(-5.6%) |
| Mar 2022 | - | $337.62 M(-11.0%) |
| Dec 2021 | $23.11 M(+12.1%) | $379.28 M(-4.2%) |
| Sept 2021 | - | $395.88 M(-1.8%) |
| June 2021 | - | $403.13 M(-5.3%) |
| Mar 2021 | - | $425.85 M(+38.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $20.62 M(-18.0%) | $308.43 M(+2.0%) |
| Sept 2020 | - | $302.24 M(-6.3%) |
| June 2020 | - | $322.62 M(-4.6%) |
| Mar 2020 | - | $338.31 M(-4.8%) |
| Dec 2019 | $25.16 M(-20.2%) | $355.25 M(-2.5%) |
| Sept 2019 | - | $364.32 M(-1.1%) |
| June 2019 | - | $368.34 M(+85.0%) |
| Mar 2019 | - | $199.15 M(-7.2%) |
| Dec 2018 | $31.53 M(-57.1%) | $214.56 M(+12.1%) |
| June 2018 | - | $191.48 M(+9.1%) |
| Dec 2017 | $73.41 M(+73.5%) | $175.53 M |
| Dec 2016 | $42.31 M | - |
FAQ
- What is NGM Biopharmaceuticals annual total current assets?
- What is the all time high annual current assets for NGM Biopharmaceuticals?
- What is NGM Biopharmaceuticals annual current assets year-on-year change?
- What is NGM Biopharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for NGM Biopharmaceuticals?
- What is NGM Biopharmaceuticals quarterly current assets year-on-year change?
What is NGM Biopharmaceuticals annual total current assets?
The current annual current assets of NGM is $156.44 M
What is the all time high annual current assets for NGM Biopharmaceuticals?
NGM Biopharmaceuticals all-time high annual total current assets is $379.28 M
What is NGM Biopharmaceuticals annual current assets year-on-year change?
Over the past year, NGM annual total current assets has changed by -$132.41 M (-45.84%)
What is NGM Biopharmaceuticals quarterly total current assets?
The current quarterly current assets of NGM is $156.44 M
What is the all time high quarterly current assets for NGM Biopharmaceuticals?
NGM Biopharmaceuticals all-time high quarterly total current assets is $425.85 M
What is NGM Biopharmaceuticals quarterly current assets year-on-year change?
Over the past year, NGM quarterly total current assets has changed by -$86.08 M (-35.49%)